Japan's medical device market is valued at USD 34.24 billion in 2025 and is projected to reach USD 60.7 billion by 2035. As regulatory demands from the Pharmaceuticals and Medical Devices Agency (PMDA) and Ministry of Health, Labour and Welfare (MHLW) grow more stringent, manufacturers face a critical challenge: delivering consistent, audit-ready product knowledge to customers, distributors, and healthcare professionals across Japan and beyond.